|
Volumn 34, Issue 10, 2003, Pages
|
Potential value of triple antiplatelet therapy for secondary stroke prevention.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADENOSINE PHOSPHATE;
ANTITHROMBOCYTIC AGENT;
CANGRELOR;
DIPYRIDAMOLE;
DRUG DERIVATIVE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
DRUG COMBINATION;
HUMAN;
LETTER;
META ANALYSIS;
RISK;
STATISTICS;
TREATMENT OUTCOME;
ADENOSINE MONOPHOSPHATE;
ASPIRIN;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIALS;
DIPYRIDAMOLE;
DRUG THERAPY, COMBINATION;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
RISK;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0242380312
PISSN: None
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/01.str.0000092896.70446.87 Document Type: Letter |
Times cited : (2)
|
References (0)
|